Ketirix

Ketotifen hydrogen fumarate, the active ingredient in Ketirix, is a mast cell stabilizer; H1 antihistamine presented as an ophthalmic preparation for ocular use. It reduces allergic inflammation by inhibiting histamine release and stabilizing ocular mast cells, providing relief from redness, itching and tearing associated with allergic eye disease.

GNH USA supplies Ketirix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Ketirix acts on ocular allergic pathways to control inflammation and histamine‑mediated symptoms.

Allergic conjunctivitis: reduces redness, swelling and itching of the conjunctiva. Itching of the eyes: alleviates discomfort caused by allergen exposure. Seasonal allergic eye inflammation: helps control symptoms during pollen seasons.

Ketirix may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging sensation upon instillation - Temporary blurred vision - Mild headache - Dry eye sensation - Redness of the conjunctiva

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Corneal ulcer or keratitis - Increased intra‑ocular pressure - Persistent eye pain or vision loss

Before using Ketirix, consider the following precautions to ensure safe and effective therapy.

Pregnancy: consult a healthcare professional before use. Breastfeeding: discuss potential risks with a physician. Contact lens wearers: remove lenses before instillation and wait before reinserting. Concurrent ocular infection: avoid use until infection is resolved. Driving or operating machinery: caution if vision is blurred after dosing. Store at room temperature: keep in original container, protect from moisture and light.

Ketirix can interact with other ocular or systemic agents; awareness of these interactions helps minimize adverse effects.

Major Interactions (Avoid): - Use with other mast cell stabilizers may increase ocular irritation.

Moderate Interactions (Monitor Closely): - Concurrent topical corticosteroids: monitor intra‑ocular pressure. - Systemic antihistamines: may add to sedation or dry‑mouth effects. - Preservative‑containing contact lens solutions: risk of increased irritation. - Non‑steroidal anti‑inflammatory eye drops: watch for additive ocular discomfort.